Literature DB >> 6193226

Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1.

F Sanchez-Madrid, P Simon, S Thompson, T A Springer.   

Abstract

Mouse Mac-1, a complement receptor-associated surface structure on macrophages, and LFA-1, a function-associated structure on lymphocytes, comprise a novel family of leukocyte differentiation antigens participating in adhesive cell interactions. Mac-1 and LFA-1 contain alpha-subunits of 170,000 and 180,000 Mr, respectively, and beta-subunits of 95,000 Mr noncovalently associated in alpha 1 beta 1 complexes. The structural relation between the alpha- and between the beta-subunits, and the location of functionally important sites on the molecules, have been probed with antibodies. Both non-cross-reactive and cross-reactive monoclonal antibodies (MAb) and antisera prepared to the purified molecules or the LFA-1 alpha-subunits were used. Reactivity with individual subunits was studied by immunoprecipitation after dissociation induced by high pH treatment, or by immunoblotting after SDS-PAGE. Cross-reactive epitopes on Mac-1 and LFA-1 were found to be present on the beta-subunits, which were immunologically identical. Non-cross-reactive epitopes that are distinctive for Mac-1 or LFA-1 were localized to the alpha-subunits. MAb to LFA-1 alpha-subunit epitopes inhibited CTL-mediated killing. Two MAb to Mac-1 alpha-subunit epitopes but not a third MAb to a spatially distinct alpha-epitope inhibited complement receptor function. Neither function was inhibited by a MAb binding to a common beta-subunit epitope. Therefore, sites of Mac-1 and LFA-1 involved in their respective adhesion-related functions, as well as distinctive structural features, have been localized to the alpha-subunits.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193226      PMCID: PMC2187359          DOI: 10.1084/jem.158.2.586

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

Review 1.  Lymphoid cell surface interaction structures detected using cytolysis-inhibiting monoclonal antibodies.

Authors:  P Golstein; C Goridis; A M Schmitt-Verhulst; B Hayot; A Pierres; A van Agthoven; Y Kaufmann; Z Eshhar; M Pierres
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

2.  Biosynthesis and assembly of the alpha and beta subunits of Mac-1, a macrophage glycoprotein associated with complement receptor function.

Authors:  M K Ho; T A Springer
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

3.  Expression and induction in vitro of macrophage differentiation antigens on murine cell lines.

Authors:  P Ralph; M K Ho; P B Litcofsky; T A Springer
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

4.  Antigens involved in mouse cytolytic T-lymphocyte (CTL)-mediated killing: functional screening and topographic relationship.

Authors:  F Sanchez-Madrid; D Davignon; E Martz; T A Springer
Journal:  Cell Immunol       Date:  1982-10       Impact factor: 4.868

5.  LFA-1 but not Lyt-2 is associated with killing activity of cytotoxic T lymphocyte hybridomas.

Authors:  Y Kaufmann; P Golstein; M Pierres; T A Springer; Z Eshhar
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

6.  Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

Authors:  F Sanchez-Madrid; A M Krensky; C F Ware; E Robbins; J L Strominger; S J Burakoff; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Monoclonal antibodies specific for rat IgG1, IgG2a, and IgG2b subclasses, and kappa chain monotypic and allotypic determinants: reagents for use with rat monoclonal antibodies.

Authors:  T A Springer; A Bhattacharya; J T Cardoza; F Sanchez-Madrid
Journal:  Hybridoma       Date:  1982

8.  Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.

Authors:  D I Beller; T A Springer; R D Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

9.  Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes.

Authors:  S D Wright; S C Silverstein
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  74 in total

1.  TGF-beta1 null mutation leads to CD154 upregulated expression in affected tissues.

Authors:  T Nakabayashi; K M Sakata; A Sakata; L Kong; C A Lau; J J Letterio; N Vela-Roch; N Talal; H Dang
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

2.  The beta-tail domain (betaTD) regulates physiologic ligand binding to integrin CD11b/CD18.

Authors:  Vineet Gupta; Annette Gylling; José Luis Alonso; Takashi Sugimori; Petre Ianakiev; Jiang-Ping Xiong; M Amin Arnaout
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

3.  Pulmonary platelet trapping induced by bleomycin: correlation with fibrosis and involvement of the beta 2 integrins.

Authors:  P F Piguet; C Vesin
Journal:  Int J Exp Pathol       Date:  1994-10       Impact factor: 1.925

4.  Contributions of molecular binding events and cellular compliance to the modulation of leukocyte adhesion.

Authors:  Ewa P Wojcikiewicz; Xiaohui Zhang; Aileen Chen; Vincent T Moy
Journal:  J Cell Sci       Date:  2003-05-06       Impact factor: 5.285

5.  The role of ICAM-1/LFA-1 and VCAM-1/VLA-4 interactions on T helper 2 cytokine production by lung T cells of Toxocara canis-infected mice.

Authors:  M Takamoto; M Isobe; K Sugane
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

6.  Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.

Authors:  Mohd Hafeez Faridi; Mehmet M Altintas; Camilo Gomez; Juan Camilo Duque; Roberto I Vazquez-Padron; Vineet Gupta
Journal:  Biochim Biophys Acta       Date:  2013-02-26

7.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits.

Authors:  C Rogers; E R Edelman; D I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules.

Authors:  H C Yan; I Juhasz; J Pilewski; G F Murphy; M Herlyn; S M Albelda
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  LFA-1 immunodeficiency disease. Definition of the genetic defect and chromosomal mapping of alpha and beta subunits of the lymphocyte function-associated antigen 1 (LFA-1) by complementation in hybrid cells.

Authors:  S D Marlin; C C Morton; D C Anderson; T A Springer
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.